Between 30% and 50% of cancer cases are preventable, and Feyi Ayodele, founder and CEO of CancerIQ, discusses how their offerings help healthcare organizations detect and prevent the acceleration of cancer in susceptible patients. CancerIQ integrates genomic medicine into routine care, automates preventive oncology processes, and expands access to genetic testing. Healthcare systems are using CancerIQ to expand or launch genetic services and improve access to testing. In 2024, CancerIQ aims to manage the increasing number of mutation carriers and high-risk patients, providing hyper-personalized cancer prevention plans and amplifying the efforts of clinicians to stay ahead of cancer.
Source link
Q&A: Partnering with providers for cancer prevention
